mardi 15 novembre 2016

Onco Actu du 15 novembre 2016

3.1 Tabac

If smoking doesn’t kill, Mike Pence, neither does the plague [The Conversation]

3.7 Alcool

10 things you might not know about alcohol and cancer [Cancer Research UK]

4.12 Biopsies liquides

Lymphoma shares secrets in its circulating tumor DNA [Stanford]

4.2 Dép., diag. & prono. - Génome

Inside the drive to collect DNA from 1 million veterans and revolutionize medicine [STAT]

5. Traitements

NCRI 2016: Could exciting new treatments to block cancer evolution halt drug resistance? [Institute of Cancer Research]

Targeting the cell’s master controller: Myc [Cancer Research UK]

A Hot Souvenir From Cuba for Some Americans: Cancer Vaccine [NY Times]

5.10 Traitements - Essais

New drug beats standard therapy in advanced kidney cancer [Dana-Farber Cancer Institute]

5.12.1 Immunothérapies - partenariats

Pfizer lines up three experimental I/O meds for NCI research tie-up [FierceBiotech]

Pfizer to Collaborate with National Cancer Institute to Study Three Immunotherapy Agents Targeting Multiple Cancers [Pfizer]

Roche launches imCORE, a global network of cancer immunotherapy centers of excellence [Roche]

Roche launches cancer immunotherapy research network [Reuters]

5.12.3 Immunothérapies-combinaisons

Immune checkpoint inhibitors shrink tumors in 26 to 38 percent of metastatic bladder cancer patients [MD Anderson Cancer Center]

5.2 Pharma

The Novartis house that Vasella built gets extreme makeover [Reuters]

5.3 Traitements - FDA, EMA, NICE...

Revising the guideline on first-in-human clinical trials [EMA]

5.3.4 Traitements - AMM (FDA, EMA)

EMA Recommends Nine Drugs for Approval [RAPS]

5.4 Traitements - Economie

Cancer drug pricing in Europe [Healthcare Economist]

NICE rebuffs Celgene's Revlimid in second-line multiple myeloma [FiercePharma]


Puma Biotechnology Announces Presentations of Investigational Data at the San Antonio Breast Cancer Symposium (SABCS) [Puma]

5.9 AACR

Blueprint Medicines to Present Preliminary Data from Ongoing Phase 1 Clinical Trials for BLU-285 and BLU-554 at 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics [PRNewswire]

6.10 Politiques

'Relentless drive' call for early cancer diagnosis [BBC News]

6.11 Patients

‘It seemed like I had climbed Mount Everest’: A rough year after daring cancer surgery [STAT]

‘Colontown’ gives cancer patients an edge in finding new treatments [STAT]

6.5 Médecines alternatives

Quackademic medicine at Memorial Sloan-Kettering Cancer Center [Respectful Insolence]

6.6 Publications

Two Harvard-led groups pull well-cited cancer papers for duplication [Retraction Watch]

A Painful (but True-to-life) Look at Data Availability and Reuse [The Scholarly Kitchen]